T2 -based MRI Delta-radiomics improve response prediction in soft-tissue sarcomas treated by neoadjuvant chemotherapy
T2 -based MRI Delta-radiomics improve response prediction in soft-tissue sarcomas [...]
Abnormal vascularization of soft-tissue sarcomas on conventional MRI: Diagnostic and prognostic values
Abnormal vascularization of soft-tissue sarcomas on conventional MRI: Diagnostic and [...]
Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival Analysis
Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival [...]
Local and Metastatic Relapse Features in Patients After a Primary Soft Tissue Sarcoma: Advocating for a Better-Tailored Follow-Up
Local and Metastatic Relapse Features in Patients After a Primary [...]
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive [...]
ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol.
ETIOSARC study : environmental aetiology of sarcomas from a [...]
Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum
Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic [...]
Alveolar soft-part sarcoma: can MRI help discriminating from other soft-tissue tumors? A study of the French sarcoma group
Alveolar soft-part sarcoma: can MRI help discriminating from other soft-tissue [...]
Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade and Patient Outcome
Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade [...]
Olaratumab failure in sarcomas: what are the lessons learned?
Olaratumab failure in sarcomas: what are the lessons learned? Italiano [...]